HT
NVCR icon

HAP Trading’s NovoCure NVCR Stock Holding History

HAP Trading’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-120,100
Closed -$9.02K – 796
2024
Q1 		$9.02K Buy
+120,100
New +$1.77M ﹤0.01% 592
2023
Q1 		– Sell
-124,500
Closed -$10.3M – 1532
2022
Q4 		$10.3M Buy
124,500
+13,700
+12% +$1.03M 1.05% 15
2022
Q3 		$9.57M Sell
110,800
-100
-0.1% -$7.8K 0.64% 35
2022
Q2 		$10.6M Sell
110,900
-200
-0.2% -$15.1K 0.53% 38
2022
Q1 		$9.64M Sell
111,100
-7,800
-7% -$575K 0.4% 43
2021
Q4 		$10.8M Buy
118,900
+7,300
+7% +$733K 0.3% 52
2021
Q3 		$7.5M Buy
111,600
+800
+0.7% +$121K 0.24% 93
2021
Q2 		$3.84M Buy
+110,800
New +$21.6M 0.12% 159

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HAP Trading's NVCR Position: Q2 2024 in Review

HAP Trading sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 82,757 shares — an estimated $1.46M sold.

HAP Trading first reported a position in NVCR in Q1 2022 and held it in 5 quarters. The position peaked at $3.35M in Q3 2022. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

  • HAP Trading reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
  • HAP Trading sold 82,757 NovoCure shares in Q2 2024, an estimated $1.46M.
  • HAP Trading first reported a position in NovoCure in Q1 2022 and held it in 5 quarters.
  • HAP Trading's NovoCure position peaked at $3.35M in Q3 2022.
  • 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on HAP Trading's 13F filing for Q2 2024, filed 14 Aug 2024.